Christine Lavoie

Prix et distinctions

• (2015) Publication award 2014. The Canadian Society for Pharmacology and Therapeutics. (Prize / Award).
• (2015) Finalist for the "Prix Jean-de-Margerie" 2014 (Best biomedical science publication). Université de Sherbrooke. (Distinction).
• (2010) Canada Research Chair in Cellular Pharmacology 2005-2010. Canadian Institutes of Health Research. (Distinction).

Financement

• Grant. (Awarded). Co-applicant. Développement de librairies ciblées de composés et étude de la neuroprotection contre la maladie de Parkinson. Fonds de recherche du Québec - Nature et technologies (FRQNT). Team research project. 150 000 $. (2023-2026)
• Grant. (Awarded). Principal Applicant. Non-canonical role of the heterotrimeric G protein Galphas (Gas) on endosomes. Natural Sciences and Engineering Research Council of Canada (NSERC). Discovery grant-Individual. 210 000 $. (2020-2025)
• Grant. (Awarded). Principal Applicant. Impact of novel ubiquitin-based Galphas regulation on receptor signaling and trafficking. Canadian Institutes of Health Research (CIHR). Project grant-Pharmacology Toxicology. 665 550 $. (2019-2024)
• Grant. (Awarded). Co-applicant. Non-canonical role of initiator caspases in colorectal cancer. Canadian Institutes of Health Research (CIHR). Project grant-Cancer Biology and Therapeutics. 669 375 $. (2019-2024)
• Grant. (Awarded). Co-investigator. Role, functions, and regulation of the delta opioid receptor and its implications for the treatment of pain. Canadian Institutes of Health Research (CIHR). Project grant-Pharmacology-Toxicology. 967 725 $. (2019-2024)
• Grant. (Completed). Principal Applicant. Non conventional role of the heterotrimeric G protein Galphas on endosomes. (2015-2020)
• Grant. (Completed). Principal Investigator. Characterization of GPR3 as a novel pharmacological target for Alzheimer's disease. Alzheimer Society of Canada. Biomedical Grant. 150 000 $. (2016-2019)

Publications

Articles de revue

• *Laniel, A., *Marouseau, E., *Nguyen, DT, Froehlich, Ul., *McCartney, C., Boudreault, PL and Lavoie, C. (2023). Characterization of PGua4, a guanidinium-rich peptoid that delivers IgGs to the cytosol via micropinocytosis. Molecular Pharmaceutics 20(3) 1577-1590 (IF 5.3). (Published).
• *Grastilleur, S., Degrandmaison, J., *Laniel, A., Grisé, O., Simard, J., Parent, J-L, Lavoie, C. and Gendron, L. (co-last authors). (2023). Constitutive Internalizationand Recycling of the Delta opioid Receptor. Mol Cell Neurosci ( (Submitted).
• Jallouli, R., Morinos Salinas, A-L, *Laniel, A., *Holleran, B., Avet, C., Bouvier, M., Carmon, K., Lavoie, C., Leduc, C. (2023). G protein selectivity profile of ADGRG1/GPR56 and its effect on downstream effectors. Pharmacological Research (Submitted).
• Sénicourt, B., Cloutier, G., Basora, N., Fallah, S., *Laniel, A., Lavoie, C., Beaulieu, JF. (2023). Primary cilium identifies a quiescent cell population in the human intestinal crypt. Cells 12(7) 1059 (IF=7.67).
• Gascon, S., Jann, J., *Langlois-Blais, C., Plourde, M., Lavoie, C. and Faucheux, N. (co-last author). (2021). Peptides Derived from Growth Factors to Treat Alzheimer's Disease. Int J Mol Sci. 22 (11), 6071. (Published).
• *Drissi, R., *Désilets, A., Leduc, R. and Lavoie, C. (2020). A polymorphic variant of GPR3 reduces amyloid beta production. In revision to Biochemical Pharmacology (BP-D-20-01838) (Revision Requested).
• Degrandmaison, J., Abdallah, K., Blais, V., Génier, S., Lalumière, M-P, *Bergeron, F., Cahill. CM., *Grastilleur, S. , Boulter, J., Lavoie, C., Parent, J-L., Gendron, L. (2020). In vivo mapping of a GPCR interactive using knock-in mice. Proc Natl Acad Sci U S A. 117 13105-13116 (IF=9.4). (Published).
• *Lanchec, E., *Désilets, A., Béliveau, F., *Fontaine-Carbonneau, C., *Laniel, A., Leduc, R. and Lavoie, C. (2020). Matriptase processing of APLP1 ectodomains alters their homodimerization. Scientific Report 22 10091 (IF=3.998). (Published).
• *Rosciglione, R., and Lavoie, C. (2019). Galphas promotes CXCR4 degradation by modulating the ubiquitination of the ESCRT-0 endosomal machinery. Submitted to MBC (Submitted).
• Khaled Abdallah, K., Nadeau, F., *Bergeron, F., Blouin, S., Blais, V., Bradbury, K., Lavoie, C., Parent, J-L and Gendron, L. (2018). Adeno-associatedvirus 2/9 delivery of Cre recombinase in mouse primary afferents. Scientific Reports 8 (1), 7321 (IF=4.3). (Published).
• *Duclos,C., Champagne,A., Carrier, C., Saucier,C., Lavoie, C. and Denault, J-B. (2017). Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. Cell Death Discovery 3 16100. (Published).
• *Duclos,C., Champagne,A., Carrier, C., Saucier,C., Lavoie, C. and Denault, J-B. (2017). Caspase play in traffic. Cell Death and Disease 8 e2636. (Published).
• *Duclos, C., Lavoie, C., and Denault, J-B. (2017). Caspases rule the intracellular trafficking cartel. FEBS review 284 ((IF= 4.2)), 1394-1420. (Published).
• Serrano, D., Ghobadi, F., Boulay, G., Ilangumaran, S., Lavoie, C., Ramanathan, S. (2017). GTPase of the immune-associated nucleotide protein 5 (GIMAP5) regulates the lysosomalcalcium compartment in T lymphocytes. Frontiers in Immunology 8 94 (IF= 5.7). (Published).
• *Li, X.Z., Letourneau, D., Lavigne, P., Holleran, B., Leduc, L., Lavoie, C. (2017). Galphas Protein Binds Ubiquitin to Regulate Epidermal Growth Factor Receptor Endosomal Sorting. Proc. Natl. Acad. Sci. U.S.A 14 13477-13482 (IF=9.7). (Published).
• *Marouseau, E., Neckebroeck, A., *Larkin, H., Le Roux, A., Volkov, A., Lavoie, C., Marsault, E. (2017). Modular sub-monomeric cell-penetrating guanidine-richpeptoids – Synthesis, assembly and biological evaluation. RSC Advances 7 6059-63 (IF=3.3). (Published).
• *Lanchec, E., Désilets, A., Béliveau, F., Leduc, R. and Lavoie, C. (2017). Processing of the Amyloid Precursor Protein by the type II transmembrane serine protease matriptase. J. Biol. Chem - (IF=4.2), -. (Published).
• *Larkin H, Costantino S, Seaman MN and Lavoie C. (2016). Calnuc function in endosomal sorting of lysosomal receptors. Traffic 17 (4), 416-32 (IF= 4.5). (Published).
• St-Louis, E., Degrandmaison, J., *Grastilleur, S., Génier, S., Blais, V., Lavoie, C., Parent, JL and Gendron, L. (2016). Involvement of the coatomer protein complex I in the intracellular traffic of the delta opioid receptor. Molecular and Cell Neuroscience 79 53-63 (IF= 3.6). (Published).
• *Li, XZ, Lavigne, P. and Lavoie, C. (2015). GGA3 Mediates TrkA Endocytic Recycling to Promote Sustained Akt Phosphorylation and Cell Survival. Molecular Biology of the Cell 26 (24), 4412-26 (IF=4.5). (Published).
• *Roscigione, S., *Thériault, C.,*Boily, M.O, *Paquette, M., and Lavoie, C. (2015). Gαs regulates the post-endocytic sorting of G protein-coupled receptors. Nature Communications 5 4556-4567 (IF=11.5). (Published).
• Traboulsi, H., *Larkin, H., Bonin, M-A, Lavoie, C. and Marsault, E. (2015). Macrocyclic Cell penetrating Peptides: a Study of Structure-Penetration Properties. Bioconjugate Chemistry 26 (3), 405-11 (IF=4.8). (Published).
• Beaudry, H., Mercier-Blais, AA., Delaygue, C., Lavoie, C., Parent, JL., Neugebauer, W., Gendron, L. (2015). Regulation of μ- and δ-Opioid Receptor Functions: Involvement of Cyclin-Dependent Kinase 5. Br J Pharmacol. 172 (10), 2573-87 (IF=4.99). (Published).
• *Larkin H , Ribeiro MG , Lavoie C. (2013). Topology and Membrane Anchoring of the Lysosomal Storage Disease-Related Protein CLN5. Human mutation 34 (12), 1688-97 (IF=5.2). (Published).
• *Brodeur J , *Thériault C , *Lessard-Beaudoin M , Marcil A , Dahan S , Lavoie C. (2012). LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease. Molecular neurodegeneration 7 (1), 31 (IF=5.3). (Published).
• Montagne M , Beaudoin N , Fortin D , Lavoie CL , Klinck R , Lavigne P. (2012). The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities. PLoS ONE 7 (2), e32172 (IF=4.4). (Published).
• Béliveau F , *Brulé C , Désilets A , Zimmerman B , Laporte SA , Lavoie CL , Leduc R. (2011). Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality. The Journal of Biological Chemistry 286 (33), 29035-43 (IF=5.3). (Published).
• Lavoie C , Roy L , Lanoix J , Taheri M , Young R , Thibault G , Farah CA , Leclerc N , Paiement J. (2011). Taking organelles apart, putting them back together and creating new ones: lessons from the endoplasmic reticulum. Progress in histochemistry and cytochemistry 46 (1), 1-48. (Published).
• *Cayouette S , Bousquet SM , Francoeur N , Dupré E , Monet M , Gagnon H , Guedri YB , Lavoie C , Boulay G. (2010). Involvement of Rab9 and Rab11 in the intracellular trafficking of TRPC6. Biochimica et biophysica acta 1803 (7), 805-812. (Published).

Chapitres de livre

• *Li, XZ, *Rosciglione, S., *Laniel, A., and Lavoie, C. (2019). Combining RNAi and Immunofluorescence Approaches to Investigate Gas-Mediated Post-Endocytic Sorting of GPCRs into Multivesicular Bodies (MVBs). Mario Tiberi. Methods in Molecular Biology (19, 303-322). United States of America : Springer Science. (Published).
• Génier S, Degrandmaison J, Lavoie C, Gendron L, Parent JL. (2019). Monitoring the Aggregation of GPCRs by Fluorescence Microscopy. Mario Tiberi. Methods in Molecular Biology (1947, 289-302). Canada : Springer Science. (Published).

Documents de travail

• *Larkin, H. and Lavoie, C. Calnuc binds and regulates CLN3 and CLN5, two proteins involved in neuronal ceroid lipofuscinosis. In preparation.

Articles de conférence

• *Laniel, A., *Marouseau, E., Marsault. E. and Lavoie, C. (2020). .A Promising New Cell Penetrating Peptoid Induces Actin Reorganization and Macropinocytosis. American Society for Cell Biology-Cell Bio Virtual 2020. (Published).
• *Laniel, A., *Marouseau, E., Marsault, E. and Lavoie, C. (2020). Characterization of a new cell penetrating peptide as intracellular delivery tool. Microscopical Society of Canada symposium, First virtual meeting. (Published).
• *Laniel,A., *Marouseau, E., Marsault, E. and Lavoie, C. (2019). Characterization of a new cell penetrating peptide as intracellular delivery tool. GPCR Retreat 2019. (Published).
• *Drissi, R, Desilets, A., Leduc, R. and Lavoie, C. (2019). GPR3 and the GPR3(R222H) polymorphism differently modulate Ab production. GPCR Retreat 2019. (Published).
• *Lanchec, E., Béliveau, F., Désilets, A, Lavoie, C and Leduc, R. (2019). Processing of amyloid-like proteins 1 and 2 (APLP1 and APLP2) by the type II transmembrane serine protease matriptase. 14th International Conference on Alzheimer's and Parkinson's disease. (Accepted).
• *Drissi, R., Leduc, R. and Lavoie, C. (2019). Signaling and trafficking of the Alzheimer's disease linked G protein coupled receptor GPR3. 14th International Conference on Alzheimer’s and Parkinson’s Diseases. (Accepted).
• *Fontaine-Carbonneau, C., *Lanchec, E Lichtenthaler, S., Leduc, R and Lavoie, C. (2019). The serine protease matriptase interacts with and cleaves the neuronal protein seizure-6. 14th International Conference on Alzheimer's and Parkinson's disease. (Published).
• *Laniel, A., *McCartney, C., *Marouseau,E., Lavoie, C. and Marsault, E. (2018). ASCB-EMBO 2018. (Accepted).
• *Bergeron, F., Berthiaume, S., Quirion, B., St-Louis, E., Blais, V., Parent, JL., Lavoie, C., and Gendron, L. (2018). Cdk5-mediated phosphorylation of delta opioid receptor: A key process for the regulation of cell surface receptors. Society for Neurosciences. (Accepted).
• *Li, X.Z., Létourneau, D., Holleran, B., Leduc, R., Lavigne, P. and Lavoie, C. (2018). Galphas protein binds ubiquitin to regulate Epidermal Growth factor Receptor endosomal sorting. 18th world congress of basic and clinical pharmacology (WCP2018). (Published).
• *Duclos CM, Champagne A, Carrier JC, Saucier C, Lavoie C and Denault JB. (2017). Cleavage of SNX2 protein by initiator caspases promotes hepatocyte growth factor (MET) receptor tyrosinekinase signaling. American Association for Cancer Research (AACR) annual meeting. (Published).
• *Li, X.Z., Létourneau, D., Holleran, B., Leduc, R., Lavigne, P. and Lavoie, C. (2017). Galphas protein binds ubiquitin to regulate Epidermal Growth factor Receptor endosomal sorting. GPCR Retreat 2017. (Published).
• *Bergeron, F., Berthiaume, S., Quirion, B., St-Louis, E., Blais, V., Parent, J-L., Lavoie, C., Gendron, L. (2017). Phosphorylation of second intracellular loop of delta opioid receptor by cdk5 : a key process for increasing its cell surface level. GPCR Retreat 2017. (Published).
• *Lanchec, E., Desilets, A., Leduc, C. and Lavoie, C. (2017). Processing of Amyloid Precursor Protein by the type II transmembrane serine protease Matriptase. 13th International Conference on Alzheimer's & Parkinson's . (Published).
• *Grastilleur, S., Parent, J.L., Lavoie, C. and Gendron,, L. (2016). Constitutive internalization of delta opioid receptors. Society for Neuroscience, San Diego, California. (Accepted).
• Lavoie, C. (2016). Galphas: un agent double dans la signalisation et le routage intracellulaire des GPCR. Signalisation Québec, Bécancour, Québec. (Published).
• *Li, X.Z., Létourneau, D., Holleran, B., Leduc, R., Lavigne, P. and Lavoie, C. (2016). Galphas protein binds ubiquitin to regulate endosomal sorting. GPCR Retreat in Chicago, USA. (Accepted).
• *Lanchec E., Leduc R. and Lavoie C. (2016). La matriptase, une sérine protéase impliquée dans la maladie d’Alzheimer?. Approches Fondamentales et Innovatrices de la Maladie Alzheimer au Québec (AFIRMAQ) 2016. (Accepted).
• *Lanchec, E., Desilets, A., Leduc, C. and Lavoie, C. (2016). Processing of Amyloid Precursor Protein by the type II transmembrane serine protease Matriptase. 2iéme « Canadian Alzheimer's Disease Basic Research Symposium (CANAD) ». (Published).
• *Grastilleur,S., Parent,J-L, Lavoie,C and Gendron, L. (2015). Constitutive internalization of delta opioid receptors. "Society of Neuroscience" in Chicago, USA. (Submitted).
• *Rosciglione, S., *Li, XZ and Lavoie, C. (2015). Galphas promotes CXCR4 degradation by modulating the ubiquitination of the ESCRT-0endosomal sorting machinery. “Great Lakes GPCR retreat” in Hockley Valley, Ontario. (Published).
• Traboulsi, H., *Larkin, H., Bonin, M-A, Volvov, L., Lavoie, C. and Marsault, E. (2015). Macrocyclic Cell penetratingPeptides: a Study of Structure-Penetration Properties. «98th Canadian Chemistry Conference» in Ottawa, Ontario. (Accepted).
• *Marouseau E., Neckebroeck A., *Larkin H., Le Roux E., Volkov L., Lavoie E., Marseault E. (2015). Synthesis and biological evaluation of constrained guanidium-rich transporters. Québec – Ontario sur la chimie de synthèse et bio-organique (QOMSBOC). (Accepted).
• *Rosciglione, S. and Lavoie, C. (2014). A new role for Galphas: regulation of the post-endocytic sorting of GPCRs. «15th GPCR Retreat» in Bromont, Quebec. (Accepted).
• *Larkin,H., *Thériault,C., Costantino, S. and Lavoie, C. (2014). The implication of Calnuc in Neuronal Ceroid Lipofuscinosis pathogenesis. «14th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease)&Patient Organization Meeting» in Corbora, Argentina. (Accepted).
• *Duclos, C, Denault, JB and Lavoie, C. (2013). Developing imaging tools to study caspase-8 activation. « 8th General Meeting of the International Proteolysis Society » in Cape Town, Africa. (Accepted).
• Serrano, D., Chen, X., Lavoie, C. and Ramanathan, S. (2013). GIMAP5 affects T cell calcium regulation by argeting multiple organelles. «the American Society for Cell Biology Meeting» in New Orleans. (Published).
• *Larkin, H, *Thériault, C. and Lavoie, C. (2012). Calnuc, a new protein involved in ceroid lipofuscinosis ?. « 13th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease) » in London, United Kingdom. (Published).
• *Roscigione, S., *Thériault, C., *Boily, M-O. and Lavoie. C. (2012). G?s, a signaling protein involved in post-endocytic trafficking of GPCRs. «13th Annual GPCR Retreat» in London, Ontario. (Published).
• *Brodeur, J., *Thériault, C. *Lessard-Beaudoin, M. and Lavoie, C. (2012). LRP10 alters APP trafficking and processing: Evidence for a role in Alzheimer’s disease. the Alzheimer’s Association International Conference on Alzheimer’s Disease in Vancouver, Canada. (Published).
• *Larkin, H, *Thériault, C. and Lavoie, C. (2012). Using tags to clarify CLN5 topology, maturation and localization. « 13th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease) » in London, England. (Published).
• Béliveau,F., *Brulé, C. Désilets, A., Zimmerman, B., Laporte, S.A., Lavoie, C. and Leduc, R. (2011). Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality. «the Seventh General Meeting of the International Proteolysis Society» in San Diego, California. (Published).
• *Rosciglione, S. and Lavoie, C. (2011). G?s: une protéine de signalisation indispensable au trafic intracellulaire des GPCR. «Association francophone pour le savoir » in Sherbrooke, Quebec. (Published).
• *Brulé, C., Désilets, A., Leduc, R. and Lavoie, C.,. (2011). LRP10 interacts with the serine protease matriptase and affects its cellular localisation and function. «the Seventh General Meeting of the International Proteolysis Society» in San Diego, California. (Published).
• *Brodeur, J., *Thériault, C. and Lavoie, C. (2011). LRP10, a new regulator of APP trafficking and processing. «the Alzheimer’s Association International Conference on Alzheimer ‘s Disease» in Paris, France. (Published).
• *Larkin, H and Lavoie, C. (2011). Le rôle de Calnuc dans le triage endosomal des recepteurs lysosomiaux. «Association francophone pour le savoir » in Sherbrooke, Quebec. (Published).
• *Roscigione, S., *Thériault, C., *Boily, M-O. and Lavoie. C. (2011). Non-traditional aspects of G?s: involvement in GPCR trafficking. “Great Lakes GPCR retreat” in Montebello, Québec. (Published).
• *Duclos, C., Denault, J-B and Lavoie, C. (2011). Spatiotemporal studies of the activation of caspase-8 in living cells. «the Seventh General Meeting of the International Proteolysis Society» in San Diego, California. (Published).
• Larkin, H. and Lavoie, C. (2010). Calnuc Function in Mannose-6-Phosphate Receptor Endosomal Sorting. «IRIC international symposium (vesicular trafficking and cellular signaling)» in Montréal, Canada. (Published).
• Larkin, H., Thériault, C. and Lavoie, C. (2010). Calnuc binds to Sortilin and affects its endosomal sorting. «Sortilins in sorting and disease» in Aarhus, Denmark. (Published).
• *Larkin, H., Costantino, S. and Lavoie, C. (2010). Calnuc function in endosomal sorting. «the American Society for Cell Biology Meeting» in Philadelphia. (Published).
• *Larkin, H. and Lavoie, C. (2010). Fonction de Calnuc dans le transport du récepteur au mannose-6- phosphate. «Club de Recherche Clinique du Québec» in Bromont, Quebec. (Published).
• *Rosciglione, S. and Lavoie, C. (2010). G?s: une protéine de signalisation indispensable au trafic intracellulaire des GPCR. « Colloque international sur les récepteurs couplés aux protéines G : perspectives montpelliéraines et sherbrookoises» in Sherbrooke, Quebec. (Published).
• *Brodeur, J., *Dupré, E. and Lavoie, C. (2010). LRP10, un nouvel acteur dans la maladie d’Alzheimer?. «Club de Recherche Clinique du Québec» in Bromont, Québec. (Published).
• Brodeur, J. and Lavoie, C. (2010). Role of LRP9, a new member of the LRP family, in Alzheimer Disease. «the Alzheimer’s Association International Conference on Alzheimer’s Disease» in Honolulu, Hawaii. (Published).
• *Duclos, C., Blais, V., Lavoie, C. and Denault, J-B. (2010). Études spatio-temporelles de la caspase-8. «Club de Recherche Clinique du Québec » in Bromont, Québec. (Published).

Autres contributions

Gestion d'évènements

• Organizing committee. (2020) 2020 Microscopy Society of Canada (MSC) First virtuall Meeting. (Conference).
• Organizing Committee. (2019) 20th GPCR Retreat , Bromont, Canada Web site: https://www.fourwav.es/view/1295/info/. (Conference).
• Chair. (2014) 15th GPCR Retreat, Bromont, Canada. (Conference).

Présentations

• (2023). Non-traditional regulation of Gαs signaling and trafficking via ubiquitination. GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors for New Therapeutic Options in Boston. United States of America
• (2019). Non-traditional aspects of Galphas: interaction with ubiquitin and regulation of endosomal sorting. Cambridge Healthtech Institute’s 14th annual ‘GPCR-Based Drug Discovery’. United States of America
• (2017). Galphas Protein Binds Ubiquitin to Regulate Epidermal Growth Factor Receptor Endosomal Sorting. GPCR Retreat 2017 in Ottawa, Ontario, Canada. Ottawa, Canada
• (2016). Galphas: un agent double dans la signalisation et le routage intracellulaire des GPCR. 7th meeting of Signalisation Québec in Bécancour, Quebec, Canada. Bécancour, Canada
• (2016). Galphas Protein Binds Ubiquitin to Regulate Endosomal Sorting. GPCR Retreat 2016 In Chicago, Illinois, USA. Chicago, United States of America
• (2015). Defining the molecular mechanisms by which Galpha-s regulates GPCR endosomal sorting. “Great Lakes GPCR retreat” in Hockley Valley, Ontario. Toronto, Canada
• (2015). Defining the molecular mechanisms by which Galphas regulates GPCR endosomal sorting. GPCR Retreat 2015. Hockley valley, Ontario, Canada
• Rosciglione, S. (presenter) and Lavoie, C. (2014). A new role for Galphas: regulation of the post-endocytic sorting of GPCRs. «15th GPCR Retreat» in Bromont, Quebec, Canada. Bromont, Canada
• Larkin, H (presenter), Thériault, C. Costantino, S. and Lavoie, C. (2014). The implication of Calnuc in neuronal ceroid lipofuscinosis pathogenesis. 14th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease). Corbora, Argentina, Argentina
• (2013). Galphas, a signaling protein involved in post-endocytic trafficking of GPCR. «Seminar organized by Department of Integrative Biology and Pharmacology, University of Texas Health Science Center». Houston, United States of America
• (2013). Galphas, une protéine de signalisation impliquées dans le triage endosomal des GPCR. «Colloque international sur les GPCR: perspective montpelliéraines et sherbrookoises». Montpellier, France
• (2012). Calnuc, a new protein involved in ceroid lipofuscinosis ?. «13th International Conference on Neuronal Ceroid Lipofuscinoses (Batten Disease)». London, United Kingdom
• Roscigione, S. (presenter), Thériault, C., Boily, M-O. and Lavoie. C. (2012). G?s, a signaling protein involved in post-endocytic trafficking of GPCRs. «13th Annual GPCR Retreat». London, Canada
• (2012). LDLR-related Protein 10 (LRP10) alters APP trafficking and processing : evidence for a role in Alzheimer’s disease. «Alzheimer’s Association International Conference» in Vancouver, Canada. Vancouver, Canada